August 24, 2012 7:39 AM | 28 seconds read |
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Eli Lilly and Company (NYSE: LLY)today announced that the primary endpoints, both cognitive and functional,were not met in either of the two Phase 3, double-blind, placebo-controlledsolanezumab EXPEDITION trials in patients with mild-to-moderate Alzheimer'sdisease. However, a pre-specified secondary analysis of pooled data acrossboth trials showed statistically significant slowing of cognitive decline inthe overall study population of patients with mild-to-moderate Alzheimer'sdisease. In addition, pre-specified secondary subgroup analyses of pooled dataacross both studies showed a statistically significant slowing of cognitivedecline in patients with mild Alzheimer's disease, but not in patients withmoderate Alzheimer's disease.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.